BCG-refractory vs. BCG-relapsing non muscle-invasive bladder cancer: A prospective cohort outcomes study

Herr Harry W.; Milan Tanya N.; Dalbagni Guido

首页> 外文期刊>Urologic oncology >BCG-refractory vs. BCG-relapsing non muscle-invasive bladder cancer: A prospective cohort outcomes study

【24h】

BCG-refractory vs. BCG-relapsing non muscle-invasive bladder cancer: A prospective cohort outcomes study

机译：BCG难治性与BCG复发性非肌肉浸润性膀胱癌：前瞻性队列研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Urologic oncology》 |2015年第3期|共1页
作者
Herr Harry W.; Milan Tanya N.; Dalbagni Guido;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. BCG-refractory vs. BCG-relapsing non muscle-invasive bladder cancer: A prospective cohort outcomes study [J] . Herr Harry W., Milan Tanya N., Dalbagni Guido Urologic oncology . 2015,第3期

机译：BCG难治性与BCG复发性非肌肉浸润性膀胱癌：前瞻性队列研究
2. Transurethral Resection of Bladder Tumor (TURBT) Followed By Partial Hypo-Fractionated Radiotherapy Concurrent with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer (MIBC): Acute Toxicities of a Prospective Phase II Study [J] . Qin S. B., Gao X. S., Zhang C. J., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：Transurethral切除膀胱肿瘤（TURBT）随后与肌肉侵袭性膀胱癌（MIBC）的患者进行部分乳腺分级放射治疗，与化疗（MIBC）：临床期II研究的急性毒性
3. Clinical behavior and outcome of papillary T1 thyroid cancers: South Korea vs. Turkey vs. Colombia in a cohort study analyzing oncological outcomes [J] . Murat Ozdemir, Yong-Sang Lee, Ozer Makay, Asian journal of surgery . 2020,第8期

机译：乳头状T1甲状腺癌的临床行为及成果：韩国与土耳其对哥伦比亚在群组中的肿瘤研究分析了肿瘤学结果
4. The In-depth quantitative proteomic and phosphoproteomic study of clinical sera derived from the Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH) cohort: The quest for potential prediction biomarkers of pharmacologic effic acy [C] . Roumeliotis T.I., Zeidan B., Vougas K., American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：临床血清的深入定量蛋白质组学和磷蛋白蛋白酶研究源自散发性患者与遗传性乳腺癌（POSH）癌症的前瞻性研究（POSH）队列：寻求药理学效应射频的潜在预测生物标志物
5. Molecular Subtyping to Stratify the Treatment of Muscle-Invasive Bladder Cancer: A Cost-Effectiveness Analysis [D] . Magee, Diana E. 2021

机译：分子亚型分析肌肉侵袭性膀胱癌的治疗：成本效益分析
6. Prognostic Value of Programmed Death Ligand-1 Expression on Tumor-Infiltrating Immune Cells in Patients Treated with Cisplatin-Based Combination Adjuvant Chemotherapy Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study [O] . Dong Hyeon Lee, Jae Yong Jeong, Wan Song 2021

机译：编程死亡配体-1对肿瘤浸润性免疫细胞对肌肉侵袭性膀胱切除术治疗的患者肿瘤浸润免疫细胞表达的预后价值：肌肉侵袭性膀胱癌：回顾性队列研究
7. Re: Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guerin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-Invasive Bladder Cancer in Intermediate-and High-Risk Patients: Final Outcome of CUETO 93009, A Randomized Prospective Trial [O] . Eduardo Solsona, Rosario Madero, VenancioChantada 2015

机译：回复：丝裂霉素C加卡介苗（BCG）的顺序组合比中等和高风险患者的非肌肉浸润性膀胱癌患者中的BCG更有效但更有毒：CUETO 93009的最终结果，a随机前瞻性试验

BCG-refractory vs. BCG-relapsing non muscle-invasive bladder cancer: A prospective cohort outcomes study

著录项

相似文献

相关主题

期刊订阅